NASH with Fibrosis Study
Ages
Location
Compensation
NASH with Fibrosis Trials in Columbus
Aventiv Research is currently participating in a NASH with fibrosis study at our Columbus, Ohio location. Non-alcoholic steatohepatitis (NASH) is a condition in which build-up of fat in the liver causes inflammation and damage in the liver. Progression of NASH leads to abnormal liver function which results in conditions like liver disease (cirrhosis), liver failure, and liver cancer.
NASH is linked to obesity, insulin resistance, high blood sugar, and high levels of fats in the blood. While some people experience fatigue or pain or swelling in the abdomen, most people do not display any symptoms, making NASH difficult to diagnose. Advances in drug therapy are key to treating this disease at its early stages and preventing further liver damage.
NASH with Fibrosis Study
The primary objective of this clinical study is to evaluate the effectiveness and safety of a once daily investigational drug compared to placebo control in patients with nonalcoholic steatohepatitis (NASH) and stage 2 liver fibrosis. You may be eligible to participate if you:
- Are 18 to 75 years of age
We now offer individuals with known risk factors of Non-Alcoholic Fatty Liver Disease (NAFLD) a free Fibroscan screening.
Ready to Volunteer?
Volunteer today to see if you qualify for our NASH with Fibrosis clinical research study. Qualified volunteers may be compensated for time and travel.